116 related articles for article (PubMed ID: 16740527)
1. The great medicines scandal.
Richards T
BMJ; 2006 Jun; 332(7554):1345-6. PubMed ID: 16740527
[No Abstract] [Full Text] [Related]
2. Developing drugs for developing countries.
Ridley DB; Grabowski HG; Moe JL
Health Aff (Millwood); 2006; 25(2):313-24. PubMed ID: 16522573
[TBL] [Abstract][Full Text] [Related]
3. Staying ahead of the fourth horseman.
Rex JH
Nat Rev Microbiol; 2004 Sep; 2(9):684. PubMed ID: 15378807
[No Abstract] [Full Text] [Related]
4. New strategies for innovation in global health: a pharmaceutical industry perspective.
Witty A
Health Aff (Millwood); 2011 Jan; 30(1):118-26. PubMed ID: 21209447
[TBL] [Abstract][Full Text] [Related]
5. The pharmaceutical industry--prices and progress.
Scherer FM
N Engl J Med; 2004 Aug; 351(9):927-32. PubMed ID: 15329432
[No Abstract] [Full Text] [Related]
6. From lab bench to Wall Street.
Bartfai T
FASEB J; 2006 Aug; 20(10):1578-80. PubMed ID: 16873880
[No Abstract] [Full Text] [Related]
7. Can we help one billion sick people?
Maliski E; Gund P; Brown F
Curr Opin Drug Discov Devel; 2008 May; 11(3):301-2. PubMed ID: 18428082
[No Abstract] [Full Text] [Related]
8. Pfizer slashes R&D.
Cressey D
Nature; 2011 Feb; 470(7333):154. PubMed ID: 21307908
[No Abstract] [Full Text] [Related]
9. Vaccine venture boosts health hopes.
Butler D
Nature; 2009 Sep; 461(7262):323. PubMed ID: 19759588
[No Abstract] [Full Text] [Related]
10. Research on hire.
Gupta AS
Issues Med Ethics; 2001; 9(4):111-3. PubMed ID: 16334912
[No Abstract] [Full Text] [Related]
11. More medicines for neglected and emerging infectious diseases.
Radisch J
Bull World Health Organ; 2007 Aug; 85(8):572. PubMed ID: 17768509
[No Abstract] [Full Text] [Related]
12. Outlook: the profit problem in antibiotic R&D.
Nathan C; Goldberg FM
Nat Rev Drug Discov; 2005 Nov; 4(11):887-91. PubMed ID: 16247440
[TBL] [Abstract][Full Text] [Related]
13. Developing drugs for parasitic diseases.
Andreopoulos S
Science; 2003 Apr; 300(5618):430-1. PubMed ID: 12702858
[No Abstract] [Full Text] [Related]
14. Cutting the cost of drug development?
Rawlins MD
Nat Rev Drug Discov; 2004 Apr; 3(4):360-4. PubMed ID: 15060531
[No Abstract] [Full Text] [Related]
15. Recruiters and industry.
Jackson M
Nature; 2004 Mar; 428(6981):450. PubMed ID: 15042100
[No Abstract] [Full Text] [Related]
16. Finding cures for tropical diseases: is open source an answer?
Maurer SM; Rai A; Sali A
PLoS Med; 2004 Dec; 1(3):e56. PubMed ID: 15630466
[TBL] [Abstract][Full Text] [Related]
17. Drug discovery veers off target.
Shaffer C
Drug Discov Today; 2005 Nov; 10(22):1489. PubMed ID: 16257367
[TBL] [Abstract][Full Text] [Related]
18. Is urological research stalled or stopped?
Wyllie MG
Curr Opin Investig Drugs; 2009 Jan; 10(1):20-2. PubMed ID: 19127483
[No Abstract] [Full Text] [Related]
19. Drug discovery alliances.
Jones A; Clifford L
Nat Rev Drug Discov; 2005 Oct; 4(10):807-8. PubMed ID: 16237845
[No Abstract] [Full Text] [Related]
20. Concerns raised over declining antiinfectives R&D.
Fox JL
Nat Biotechnol; 2003 Nov; 21(11):1255-6. PubMed ID: 14595340
[No Abstract] [Full Text] [Related]
[Next] [New Search]
